1. SHARED BASED COMPENSATION
 
  • $3.017M was included in the financials as an expense for accounting purposes
  • What instiitutional, fund mgrs and smart money will glean from the Q3 Financials is actual cash flows and discern and realize the non cash expenses. 
From Pg 4 of the MD & A  - Share-based expense   ($3,017,408)   is employee options

*Options @$4.41  granted on July 16,2020 as per press released July 16,2020

** NOTE: - This was a non cash expense based on employee options granted by the company for motivational purposes.
Accounting treats it like salary for accounting purposes BUT does not reflect on cash basis so we must net it out to understand the financial metrics properly. 
  • Thus adding back this ($3,017,408) to the NOI stated gives and actual $3,122,547. 

3. % Complete
  • The  line item of "billings in excess of cost and profits on uncompleted projects" is NOT an actual liability as stated, but an accounting principle that was created bc of the Enron scandal days where they were cooking the books 
  • Companies can only book % of project complete regardless of the cash received for that project  
3. Strategic Investments 

  • $15.15M increase in HPQ  Strategic Investments is NOT an idependent investment. 
  • The strategic investment gain from HPQ that effects income in the amount of $15MM, which actually used to be listed under PYR operations but as of few years ago has been pulled out and listed as a strategic investment.
  • HPQ consists of only a few people and a board - PYR is doing all the work
  • PYR team, facility,tech/engineering etc ie HPQ is breathing and living bc of PYR
  • IF PYR invested in a seperate independent investment totally unrelated like let's say Pfizer one can say oh what a bonus BUT not in this case as HPQ is highly dependent on PYR. 
  • This is legally and for practical purposes directly related to PYR's performance
  • A simple good example might be if they spin out 3D powder division and retain % share ownership or even invest more in future, the gain in 3D Newco would still be very correlated to PYR's performance as 3D Newco  breathes and lives bc of PYR. 
  • Simply put the PUREVAP NANO Reactor NSiR and Purevap Quartz Reduction Reactor QRR are both sitting inside PYR faciities staffed by PYR along w PYR's engineering. 
 
 
4. Looking Forward:

  • PYR historically had revenues at best of $5-7M per annum but now they just reported $8.15M for Q3.  EPS of $.10 is extremely stellar and PYR will continue and build upon. 
  • Current cash on hand of $17M , NO DEBT on balance sheet and $36M in backlogged signed contracts.
  • As Pete stated he is "buillding a business dynasty" previously stated 'building an empire' and truly is 'warp speed'. 
 
  • One important note for some who  doubt Pyrogenesis / HPQ’s  Purevap NANO ability and continue to post seeds of doubt: 
    Pyrogenesis engineering has accredited 3D powders by major aerospace company plus usa military waste destruction etc. Silicon nano-powders and nanowires won't be hard for them. Hence the extreme confidence of both CEOs.
  • Purevap silicon nano-powders and nanowires will be scaled...you can bet on that. Why else would Pyrogenesis buy more shares of HPQ at 50% premium last private placement ? That's bc they are in the know..insider.  

  • They are about  to disrupt massive industriess w silicon nano-powders and nanowires. EV battery market, Hydrogen energy market, plus medical and countless other applications with their Golden Goose PUREVAP SILICON NANO-POWDERS REACTOR is going to be sensational. At least two multi billion dollar market opportunities alone for HPQ and PyroGenesis is going to be really amazing.  
  • Pyrogenesis has so many divisions is really hard to keep up:
    PUREVAP NANO, 3D POWDERS, WASTE DESTRUCTION, TUNNELING, DROSITE and other PYR applications each on it's own can and will become massive - please let that sink in for a moment or two. 

LONG AND STRONG PYR!!!!!!!!!

MD&A - English https://www.sedar.com/GetFile.do?lang=EN&docClass=7&issuerNo=00031955&issuerType=03&projectNo=03140628&docId=4841464 Interim financial statements/report - English https://www.sedar.com/GetFile.do?lang=EN&docClass=5&issuerNo=00031955&issuerType=03&projectNo=03140627&docId=4841468